Current problems in cancerHumansFemaleBreast NeoplasmsNeoadjuvant TherapyRetrospective Studies
Electronic symptom monitoring improves chemotherapy dose intensity in neoadjuvant chemotherapy for breast cancer.
Yuki Takei, Atsufumi Nomoto, Mizuki Kawashima, Yuko Miyake, Arisa Kawakami, Tadamitsu Shima, Isao Teshima, Natsumi Nomoto, Yoshiharu Mitsunaga, Tamaki Watanabe, Yukie Nagase, Nobuhiro Yasuno
Published: 202610.1016/j.currproblcancer.2025.101266
Abstract
PURPOSE: The present study investigated the clinical impact of electronic patient-reported outcome (ePRO) monitoring on chemotherapy dose intensities and adverse event (AE) management in patients with early-stage breast cancer receiving neoadjuvant c…
Preview only. Read the full abstract at the source